Organ Transplant Is Pushing the Growth of Immunosuppressive Drug

Published: Mar 2021

The global immunosuppressive drug market is anticipated to grow at a considerable CAGR of 14.2% during the forecast period (2021-2027). The immunosuppressive drug is used to slow down the response of the immune system so that the organ does not get rejected by the body. The drug prevents the transplanted organ from getting damaged by the body. 

The market growth is mainly attributed to the increasing transplant due to organ failure across the globe. Many people need organ transplants due to various factors such as damage of organs due to chronic diseases for instance diabetes, various types of infections such as hepatitis. Moreover, physical injuries to organs and genetic conditions such as heart defect, kidney disease are other causes for organ transplant and which requires immunosuppressive drug in the later stages of treatment. As per Health Resource and Service Administration, around 39,000 transplants were performed in 2020 in the US. However, there were more than 107,000 people including children were in waiting for organ transplants in the US. It represents a significant gap in the supply and demand of organ transplants even in the developed economies. 

Browse the full report description of "Immunosuppressive Drug Market Share, Growth, Competitive Analysis By Application (Heart Transplant, Kidney Transplant, Liver Transplant, Lungs Transplant, and other), By Drug Class (, Calcineurin Inhibitor, Antiproliferative Agent, mTOR Inhibitors, Steroids and other), By Drug Type (Patented and Generic) Forecast Period 2021-2027" at https://www.omrglobal.com/industry-reports/immunosuppressive-drug-market

However, as immunosuppressive drug have its advantage as well as it has some disadvantages also such as it diminish the strength of the immune system of the human body that results in lowering the detecting and fighting power of immune system from cancer cells which is a restrictive factor for the market growth. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2020-2027
  • Segment Covered- 

o By Application

o By Drug Type

  • Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

  • Competitive Landscape- AbbVie, Inc., Bristol-Myers Squibb Co., Novartis AG, Pfizer, Inc., Sanofi SA

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?
  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Immunosuppressive Drug Market Report Segment

By Application

  • Heart Transplant
  • Kidney Transplant
  • Liver Transplant
  • Lungs Transplant
  • Other

By Drug Class

  • Calcineurin Inhibitor
  • Antiproliferative Agent
  • Motor Inhibitors
  • Steroids 
  • Other

By Drug Type

  • Patented 
  • Generic

Global Immunosuppressive Drug Market Report Segment by Region

North America           

  • US
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia-Pacific    

  • China
  • Japan
  • India
  • Rest of Asia-Pacific

Rest of the World

  • Middle East & Africa 
  • Latin America 

To learn more about this report request a sample copy @  https://www.omrglobal.com/request-sample/immunosuppressive-drug-market